Drug Approval | November 22, 2021
Amneal gets approval for Difluprednate ophthalmic emulsion
The company is moving towards complex and more differentiated products
The company is moving towards complex and more differentiated products
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The union health ministry notifies the protocol and this move will also help in organ donation
This test is inexpensive and results are available immediately as compared to the genetic test
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Acute therapies continue to report strong growth compared to chronic ones.
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
Subscribe To Our Newsletter & Stay Updated
